• We are a fully integrated
    vaccine company with two
    travel vaccines on the market.

  • Dedicated to innovation
    in vaccine research and
    development.

  • Valneva’s lead clinical late
    stage programs address
    hospital and healthcare
    associated infections.

  • Valneva covers the full
    value chain from research
    to market.

 

Welcome to Valneva

A leading pure play vaccine company.

VAL_Banner_ABR2014_small.jpg

— February 2, 2016

Valneva Evaluating Development of Zika Vaccine as Virus Spreads Through the Americas
Read more

— Stock information

@valnevase




















-

—News, Nov. 9, 2015

Valneva Announces U.S. Distribution and Marketing Services Agreements with VaxServe 

 Read more

— Financial Calendar



Estimated Q4 & FY Results 2015
February 24, 2016

Final Q4 & FY Results 2015
March 21, 2016

Q1 Results 2016
May 11, 2016

Annual General Meeting
June 30, 2016

See all dates

AKTUELLES

News in German


 

VALNEVA
LIBRARY

Images, presentations and videos

PIPELINE OF
VACCINE
CANDIDATES




learn more
play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

– Upcoming conferences and fairs



World Vaccine Congress US 2016
Washington D.C., US
March 29-31, 2016










map

A leading pure play vaccine company with international footprint.

Locations
Please update your browser...